Efficacious oxime for organophosphorus poisoning: A minireview

Tropical Journal of Pharmaceutical Research

Volumn 10, Issue 3, 2011, Pages 341-349

  Nurulain, Syed M ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Acetylcholinesterase reactivators; Bispyridinium aldoxime; K 27 and K 48 oxime; K oximes; OPC poisoning; References

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; CHOLINESTERASE; CHOLINESTERASE REACTIVATOR; K 27; K 27 OXIME; K 48; K 48 OXIME; OBIDOXIME; ORGANOPHOSPHORUS COMPOUND; OXIME; PRALIDOXIME; TRIMEDOXIME; UNCLASSIFIED DRUG;

CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; CZECH REPUBLIC; DRUG EFFICACY; DRUG STRUCTURE; IN VITRO STUDY; IN VIVO STUDY; INTOXICATION; ISRAEL; NONHUMAN; PHYSICAL CHEMISTRY; REVIEW; UNITED STATES;

EID: 79959956999     PISSN: 15965996     EISSN: 15969827     Source Type: Journal    
DOI: 10.4314/tjpr.v10i3.10     Document Type: Review

References (55)

1. Buckley NA, Eddleston M, Dawson AH. The need for translational research on antidotes for pesticide poisoning. Clin Exp Pharmacol Physiol 2005; 2: 999-1005.
2. Eddleston M, Buckley N, Eyer P, Dawson A. Management of acute organophosphorus poisoning. The Lancet 2008; 371(9612): 597-607.
3. Kavalci C, Durukan P, Ozer M, Cevik Y, Kavalci G. Organophosphate poisoning due to a wheat bagel. Inter Med 2009; 48: 85-88.
4. Cherian MA, Roshini C, Peter JV, Cherian AM. Oximes in organophosphorus poisoning. IJCCM 2005; 9(Pt 3): 155-163.
5. Karalliedde L, Senanayake N. Organophosphorus insecticide poisoning. J Int Fed Clin Chem 1999; 11(2): 4-9.
6. World Health Organization Public health impact of pesticides used in agriculture. 0edn. WHO; Geneva 1990.
7. Kenneth DK, Daniel EB, Kisa K. Toxicity, Organophosphate. [cited 2011 Feb 8]. Available from http://emedicine.medscape.com/article/167726 overview
8. Littefield MH. Estimates of acute pesticide poisoning in agricultural workers in less developed countries. Toxicol Rev 2005; 24: 271-278.
9. Marrs TC. Organophosphate poisoning. Pharmacol Therapeut 1993; 58(1): 51-61.
10. Mileson BE, Chambers JE, Chen WL, Dettbarn W, Ehrich M, Eldefrawi AT, Gaylor DW, Hamernik K, Hodgson E, Karczmar AG, Padilla S, Pope CN, Richardson RJ, Saunders DR, Sheets LP, Sultatos LG, Wallace KB. Common mechanism of toxicity: A case study of organophosphorus pesticides. Toxicol Sci 1998; 41: 8-20.
11. Pope CN. Organophosphorus pesticides: Do they all have same mechanism of toxicity? J Toxicol Environ Health (Part B) 1999; 2(Pt 2): 161-181.
12. Wilson IB, Ginsburg SA. Powerful reactivator of alkyl phosphate inhibited acetylcholinesterase. Biochim Biophys Acta 1955; 18: 168-170.
13. Namba T, Hiraki K. PAM (pyridine-2-aldoxime methiodide) therapy for alkyl-phosphate poisoning. J Am Med Assoc 1958; 166: 1834-1839.
14. Antonijevic B, Stojijkovic MP. Unequal efficacy of pyridinium oximes in acute organophosphate poisoning. Clin Med Res 2007; 5(Pt 1): 71-82.
15. Stojiljkovic MP, Jokanovic M. Pyridinium oximes: Rationale for their selection as casual antidotes against organophosphate poisonings and current solutions for auto injectors. Arh Hig Rada Toksikol 2006; 57: 435-443.
16. Worek F, Eyer P, Aurbek N, Szinicz L, Thiermann H. Recent advances in evaluation of oxime efficacy in nerve agent poisoning by in vitro analysis. Toxicology and Applied Pharmacology 2007; 219: 226-234.
17. Kassa J, Kuča K, Cabal J, Paar M. Comparison of the efficacy of new asymmetric bispyridinium oximes (K-27, K-48) with currently available oximes against tabun by in vivo methods. J Toxicol Environ Health A 2006; 69: 1875-1882.
18. Peter JV, Cherian AM. Organic insecticides. Anaesth Intensive Care. 2000; 28: 11-21.
19. Peter JV, Moran JL, Graham P: Oxime therapy and outcomes in human organophosphate poisoning: an evaluation using meta-analytic techniques. Crit Care Med 2006; 34: 502-510.
20. Johnson MK, Jacobsen D, Meredith TJ, Eyer P, Heath AJ, Ligtenstein DA, Marrs TC, Szinicz L, Vale JA, Haines JA. Evaluation of antidotes for poisoning by organophosphorus pesticides. Emer Med 2000; 12: 22-37.
21. Petroianu GA. Poisoning with organophosphorus compound (OPC): Mythology vs. Reality. The Middle East J Emer Med 2006; 6(Pt 1): 3-8.
22. Eddleston M, Szinicz L, Eyer P, Buckley N. Oximes in acute organophosphorus pesticide poisoning: a systematic review of clinical trials. QJM 2002; 95: 275-283.
23. Kassa J, Kuca K, Bartosova L, Kunesova G. The development of new structural analogues of oximes for the antidotal treatment of poisoning by nerve agents and the comparison of their reactivating and therapeutic efficacy with currently available oximes. Curr Org Chem 2007; 11: 267-283.
24. Worek F, Thiermann H. Strategies for the development of effective broad spectrum oximes. In defence against the effects of Chemical Hazards: Toxicology, diagnosis and medical countermeasures 2007; p 301-306.
25. Primozic I, Odzak R, Tomic S, Simeon-Rudolf V, Reiner E. Pyridinium, imidazolium and quinuclidinium oximes: synthesis, interaction with native and phosphylated cholinesterase and antidotes against organophosphorus compounds. J Med Chem Def 2004; 2: 1-30.
26. Kuča K, Bielavský J, Cabal J, Bielavska M. Synthesis of a potential reactivator of acetylcholinesterase - 1-(4- hydroxyiminomethylpyridinium)-3- (carbamoylpyridinium) -propane dibromide. Tetrahedron Lett 2003; 44: 3123-3125.
27. Jokanovic M. Medical treatment of acute poisoning with organophosphorus and carbamate pesticides. Toxicol Lett 2009; 190: 107-115.
28. Kassa J, Kuca K, Karasova J, Musilek K. The development of new oximes and the evaluation of their reactivating, therapeutic and neuroprotective efficacy against tabun. Mini Rev Med Chem 2008; 8(11): 1134-1143.
29. Calic M, Vrdoljak AL, Radic B, Jelic D, Jun D, Kuča K, Kovarik Z. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity. Toxicology 2006; 219: 85-96.
30. Musilek K, Holas O, Kuca K, Jun D, Dohnal V, Dolezal M. Synthesis of assymetrical bispyridinium compounds bearing cyano moiety and evaluation of their reactivation activityagainst tabun and paraoxon-inhibited acetylcholinesterase. Bioorg Med Chem Lett 2006; 16: 5673-5676.
31. Musilek K, Kuca K, Jun D, Dohnal V, Dolezal M. Synthesis of the novel series of bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase. Bioorg & Med Chem Lett 2006; 16: 622-627.
32. Petroianu GA, Arafat K, Kuča K, Kassa J. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon. J Appl Toxicol 2006; 26: 64-71.
33. Petroianu GA, Nurulain SM, Nagelkerke N, Al- Sultan MA, Kuča K, Kassa J. Five oximes (K- 27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: survival in rats exposed to the organophosphate paraoxon. J Appl Toxicol 2006; 26: 262-268.
34. Petroianu GA, Nurulain SM, Nagelkerke N, Shafiullah M, Kassa J, Kuča K. Five oximes (K-27, K-48, obidoxime, HI-6 and trimedoxime) in comparison with pralidoxime: survival in rats exposed to methyl-paraoxon. J Appl Toxicol 2007; 27: 453-457.
35. Petroianu GA, Hasan MY, Nurulain SM, Nagelkerke N, Kassa J, Kuča K. New K-oximes (K-27 and K-48) in comparison with obidoxime (LuH-6), pralidoxime, HI-6 and trimedoxime (TMB-4): survival in rats exposed to the organophosphate paraoxon. Toxicol Mech Method 2007; 17: 401-408.
36. Lorke DE, Hasan MY, Nurulain SM, Kuca K, Schmitt A, Petroianu GA. Efficacy of two new asymmetric bispyridinium oximes (K-27 and K- 48) in rats exposed to diisopropylfluorophosphate (DFP): comparison with the established oximes pralidoxime, obidoxime, trimedoxime, methoxime and HI-6. Clin Toxicol 2008; 23: 1-7.
37. Lorke DE, Hasan MY, Nurulain SM, Kuca K, Kassa J, Petroianu GA. Eight new bispyridinium oximes in comparison with the conventional oximes pralidoxime and obidoxime: In vivo efficacy to protect from diisopropylfluorophosphate (DFP) toxicity. J Appl Toxicol 2008; 28(Pt 7): 920-928.
38. Nurulain SM, Lorke DE, Hasan MY, Shafiullah M, Kuca K, Musilek K. Efficacy of eight experimental bispyridinium oximes against paraoxon induced mortality: Comparison with the conventional oximes pralidoxime and obidoxime. Neurotox Res 2009; 16(Pt 3): 60-67.
39. Kuca K, Bielavský J, Cabal J, Bielavska M. Synthesis of a potential reactivator of acetylcholinesterase - 1-(4- hydroxyiminomethylpyridinium)-3- (carbamoylpyridinium) -propane dibromide. Tetrahedron Lett 2003; 44: 3123-3125.
40. Kuča K, Bielavský J, Cabal J, Kassa J. Synthesis of a new reactivator of tabuninhibited acetylcholinesterase. Bioorg Med Chem Lett 2003; 13: 3545-3547.
41. Kuča K, Musilek K, Jun D, Pohanka M, Ghosh KK, Hrabinova M. Oxime K027: novel lowtoxic candidate for the universal reactivator of nerve agent and pesticide inhibited acetylcholinesterase. J Enz Inhib Med Chem 2010; 25(4): 509-512.
42. Kuča K, Jun D Musilek K. Structural requirements of acetylcholinesterase reactivators. Mini Rev Med Chem 2006; 6(3): 269-277.
43. Musilek K, Dolezal M, Gunn-Moore F, Kuca K. Design, evaluation and structure-activity relationship studies of the AChE reactivators against organophosphorus pesticides. Med Res Rev 2009; Dec 21. DOI:10.1002/med.20192
44. Maxwell DM, Koplovitz I, Worek F, Sweeney RE.: A structure-activity analysis of the variation in oxime efficacy against nerve agents. Toxicology Applied Pharmacology 2008; 231: 157-164.
45. Lorke DE, Hasan MY, Nurulain SM, Sheen R, Kuča K, Petroianu GA. Entry of two new asymmetric bispyridinium oximes (K-27 and K-48) into the rat brain: comparison with obidoxime. J Appl Toxicol 2007; 27: 482-490.
46. Lorke DE, Petroianu GA. Minireview: does invitro testing of oximes help predict their invivo action after paraoxon exposure? J Appl Toxicol 2009; (6): 459-469.
47. Dawson RM. Review of oximes available for treatment of nerve agent poisoning. J Appl Toxicol 1994; 14(5): 317-31.
48. Berend S, Radic B, Kuca K, Lucić Vrdoljak A. The antidotal efficacy of the bispyridinium oximes K027 and TMB-4 against tabun poisoning in mice. Chem Biol Interact 2010; 187(1-3): 291-294.
49. Lorke DE, Hasan MY, Nurulain SM, Kuca K, Schmitt A, Petroianu GA. Efficacy of two new asymmetric bispyridinium oximes (K-27 and K- 48) in rats exposed to diisopropylfluorophosphate: comparison with pralidoxime, obidoxime, trimedoxime, methoxime, and HI-6. Toxicol Mech Methods 2009; 19(4): 327-333.
50. Kassa J. The influence of oxime and anticholinergic drug selection on the potency of antidotal treatment to counteract acute toxic effects of tabun in mice. Neurotox Res, 2006; 9(1): 59-62.
51. Lorke DE, Hasan MY, Arafat K, Kuča K, Musilek K, Schmitt A, Petroianu GA. In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by diisopropylfluorophosphate (DFP). J Appl Toxicol, 2008; 28(4): 422-429.
52. Petroianu GA, Kalasz HJ. Comparison of the ability of oximes to reactivate human RBC cholinesterases inhibited by ethyl- and methylparaoxon. Curr Org Chem, 2008; 11: 1624-1634.
53. Kuca K, Bartosova L, Kassa J, Cabal J, Bajgar J, Kunesova G, Jun D. Comparison of the potency of newly developed and currently available oximes to reactivate nerve agentinhibited acetylcholinesterase in vitro and in vivo. Chem Biol Interact, 2005; 157/158: 367-368.
54. Kuca K, Marek J, Karasova J, Pohanka M, Korabecny J, Kalasz H. Novel Acetylcholinesterase Reactivator - Oxime K048 - Reactivation Activity In vitro. Med Chem, 2010; 6(1): 1-5.
55. Kuca K, Kassa J. A comparison of the ability of a new bispyridinium oxime-1-(4-hydroxyiminomethylpyridinium)- 4-(4-carbamoylpyridinium) butane dibromide and currently used oximes to reactivate nerve agent inhibited ratbrain acetylcholinesterase by in vitro methods. J Enz Inhib Med Chem, 2003; 18(6): 529-535.